The US Department of Agriculture approved the genetically modified purple tomato to extend its shelf life and boost nutritional quality almost 15 years after its development.
According to biochemist Cathie Martin, she and her colleagues at Norfolk Plant Scientists (NPS) have been experimenting with pigment production in flowering plants for over two decades, and they've spent almost 15 months developing the purple tomato.
The NPS has been focusing on anthocyanins, the antioxidant-rich pigments that give blackberries and blueberries their signature shades.
Domesticated tomatoes already have genes to produce anthocyanins, but they are not 'turned on.' By carefully adding two genes, the tomatoes and juice become a rich source of antioxidants, because purple pigments are made in the whole tomato, not just the skins.
While there are already some purple-skinned tomatoes, their pigments mostly stop at the outer layers and don't accumulate in the fruit itself.
The NPS also emphasized that there is increasing evidence to show that antioxidants work much better when consumed within foods.
The USDA Animal and Plant Health Inspection Service (APHIS) reported that the tomato was modified to alter its color and enhance its nutritional quality, adding that the plant is unlikely to pose an increased plant pest risk compared to other cultivated tomatoes.
Nathan Pumplin, the CEO of NPS' US-based commercial business, said they are optimistic that they can begin limited distribution of purple tomatoes in the US by 2023.


Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Jared Isaacman Confirmed as NASA Administrator, Becomes 15th Leader of U.S. Space Agency
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Australia’s December Trade Surplus Expands but Falls Short of Expectations
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
SpaceX Starship Test Flight Reaches New Heights but Ends in Setback
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
Asian Markets Slip as AI Spending Fears Shake Tech, Wall Street Futures Rebound
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility 



